IMCD stock sits 1.75 percent below its 52-week high at EUR 103.60

Published on 10/19/2026 at 10:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

IMCD will publish first nine months results on November 5, 2026. IMCD stock costs EUR 103.60 on October 19, 2026, 0.38 percent below the Xetra close.

Results and operating progress

IMCD will publish its first nine months 2026 results on November 5, 2026.
Operating EBITA reached EUR 285.00 million in the first half of 2026, up 4.00 percent.
IMCD stock trades at EUR 103.60 at 10:01 a.m. CEST at Lang & Schwarz on October 19, 2026, 0.38 percent below the Xetra close of October 16, 2026.

Schwarzweiß-Dokumentarfoto von Arbeitern bei Kontrolle chemischer Lagertanks in Industriehalle — Schwarzweiß-Reportage dokumentiert Qualitätskontrolle bei IMCD N.V., ISIN NL0010801007, in chemischer Lagerhalle authentisch, Illustration mit AI erstellt.

IMCD (ISIN NL0010801007) was trading at EUR 103.60 at Lang & Schwarz on October 19, 2026, at 10:01 a.m. CEST, placing IMCD stock 1.75 percent below its 52-week high of EUR 105.55. The specialty chemicals distributor is preparing its next scheduled results release, with the date confirmed by GlobeNewswire on October 15, 2026.

Three events shape the picture

On July 29, 2026, IMCD reported first-half operating EBITA of EUR 285.00 million, up 4.00 percent, according to 6ix.

On October 2, 2026, Goldman Sachs placed IMCD on its European conviction list and set a EUR 133.00 price target, as reported by Traders Union. On October 15, 2026, IMCD confirmed that first nine months results would be published on November 5, 2026, at 7:00 a.m. CET, followed by a 9:00 a.m. CET webcast.

What does the next report test?

The September quarter will show whether the first-half improvement in operating EBITA can continue as IMCD moves through the second half of 2026. The latest reported first-half revenue was EUR 2.65 billion, up 6.60 percent from the first half of 2025, while earnings per share rose to EUR 2.41 from EUR 2.20, according to Simply Wall St. The comparison gives investors two operating markers for the November update: revenue growth and profit conversion.

Dates set the next checkpoint

IMCD lists November 5, 2026, for the first nine months 2026 results and February 19, 2027, for full-year 2026 results. The calendar gives the stock a defined reporting catalyst rather than an open-ended earnings window.

Stock stays below yearly high

IMCD has a market capitalization of EUR 6.1 billion as of October 19, 2026. Its 52-week range is EUR 68.14 to EUR 105.55, leaving the current quote EUR 1.95 below the upper end of that range. The stock is listed on Euronext Amsterdam under ticker IMCD, and the company operates in specialty chemicals distribution.

IMCD was trading at EUR 103.60 at Lang & Schwarz on October 19, 2026, at 10:01 a.m. CEST, down 0.38 percent versus the Xetra close of October 16, 2026, at EUR 104.00. The further course of trading is shown by the continuously updated real-time quote of IMCD stock.